|
Uses and Applications | Advantages Over Traditional Treatment | Cost Savings
Uses and Applications For State and Local Agencies
The Numobag™ has many uses for state and local agencies:
- Chemical, electrical and heat burns
- Biological-warfare related lesions
- Lesions from smallpox, anthrax and other diseases
- Large numbers of infected people
Numobag™ may be used to:
- Contain biological, chemical and nuclear attacks
- Treat single or mass casualties
- Perform quickly: 3 minutes to install, 1 minute to remove
- Create an instant, disposable isolation unit
- Stop advancement of insidious forms of biological attack: dermal anthrax, smallpox, necrotizing fasciitis, etc.
THOT™ heals more often, faster and with less scarring than traditional treatment of skin wounds. It was used to treat 9/11 World Trade Center burn victims with favorable results. The U.S. military is currently using Numobag™ in Iraq.
Clinical case studies:
Advantages Over Traditional Treatment
- No cross-contamination
- Small and portable (weights 1.7 pounds)
- Patient does not have to be moved for treatment
- Multiple patients treated simultaneously
- Decreased cost of overall treatment
- Lower cost per treatment than any other wound treatment method
- Quick usage in emergency for any type of wound
- Inexpensive and disposable isolation ward
- Front-line tool for reducing cross-contamination and infection of medical personnel
- Mass casualty treatment in critical initial wounds care emergency
- Multiplies first responders efforts to reduce immediate overload
- Able to be stored for years without maintenance or constant surveillance
Cost Savings
During an effectiveness study, Numobag™ was found to be not only more effective than traditional treatments, but also notably more cost effective.
Level 2 Ulcers
| |
Control Patients |
THOT™ Patients |
Acute care costs
Transitional care
Outpatient costs
THOT™ costs |
$7,778
$1,479
$450
$0 |
$5,002
$423
$0
$1,480 |
| Total cost/ulcer |
$9,707 |
$6,905 |
| Healed at 4 weeks |
0% |
100% |
|
Level 3 Ulcers
| |
Control Patients |
THOT™ Patients |
Acute care costs
Transitional care
Outpatient costs
THOT™ costs |
$11,126
$2,824
$1,156
$0 |
$7,651
$1,000
$130
$2,220 |
| Total cost/ulcer |
$15,106 |
$11,001 |
| Healed at 6 weeks |
0% |
80% |
|
Level 4 Ulcers
| |
Control Patients |
THOT™ Patients |
Acute care costs
Transitional care
Outpatient costs
THOT™ costs |
$14,258
$13,947
$1,845
$0 |
$11,098
$2,223
$230
$2,960 |
| Total cost/ulcer |
$30,050 |
$16,511 |
| Healed at 12 weeks |
0% |
83.3% |
|
Ostomy/Wound Management published a peer-reviewed, randomized clinical study documenting the efficacy and cost savings of Numobag™ treatments.
The cost savings of Numobag™ use results from reduced use of specialty beds, intravenous antibiotics, nursing and dressing costs, and surgical procedures. It also immediately treats Stage II wounds to prevent progression to more serious stages.
|
